LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

PKS_AT domain-containing protein

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
PKS_AT domain-containing protein
Gene product:
acyl transferase-like protein, putative
Species:
Leishmania major
UniProt:
E9AFH1_LEIMA
TriTrypDb:
LmjF.35.3470 , LMJLV39_350042100 * , LMJSD75_350041600 *
Length:
532

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 10
NetGPI no yes: 0, no: 10
Cellular components
Term Name Level Count
GO:0005835 fatty acid synthase complex 3 2
GO:0032991 protein-containing complex 1 2
GO:0140535 intracellular protein-containing complex 2 2
GO:1902494 catalytic complex 2 2

Expansion

Sequence features

E9AFH1
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: E9AFH1

Function

Biological processes
Term Name Level Count
GO:0006082 organic acid metabolic process 3 4
GO:0006629 lipid metabolic process 3 4
GO:0006631 fatty acid metabolic process 4 4
GO:0006633 fatty acid biosynthetic process 5 4
GO:0008152 metabolic process 1 4
GO:0008610 lipid biosynthetic process 4 4
GO:0009058 biosynthetic process 2 4
GO:0009987 cellular process 1 4
GO:0016053 organic acid biosynthetic process 4 4
GO:0019752 carboxylic acid metabolic process 5 4
GO:0032787 monocarboxylic acid metabolic process 6 4
GO:0043436 oxoacid metabolic process 4 4
GO:0044237 cellular metabolic process 2 4
GO:0044238 primary metabolic process 2 4
GO:0044249 cellular biosynthetic process 3 4
GO:0044255 cellular lipid metabolic process 3 4
GO:0044281 small molecule metabolic process 2 4
GO:0044283 small molecule biosynthetic process 3 4
GO:0046394 carboxylic acid biosynthetic process 5 4
GO:0071704 organic substance metabolic process 2 4
GO:0072330 monocarboxylic acid biosynthetic process 6 4
GO:1901576 organic substance biosynthetic process 3 4
Molecular functions
Term Name Level Count
GO:0003824 catalytic activity 1 11
GO:0004312 fatty acid synthase activity 5 4
GO:0004314 [acyl-carrier-protein] S-malonyltransferase activity 6 2
GO:0016417 S-acyltransferase activity 5 2
GO:0016419 S-malonyltransferase activity 6 2
GO:0016420 malonyltransferase activity 5 2
GO:0016740 transferase activity 2 11
GO:0016746 acyltransferase activity 3 4
GO:0016747 acyltransferase activity, transferring groups other than amino-acyl groups 4 4

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 275 279 PF00656 0.506
CLV_C14_Caspase3-7 91 95 PF00656 0.490
CLV_NRD_NRD_1 177 179 PF00675 0.393
CLV_NRD_NRD_1 307 309 PF00675 0.547
CLV_NRD_NRD_1 358 360 PF00675 0.421
CLV_NRD_NRD_1 394 396 PF00675 0.545
CLV_NRD_NRD_1 504 506 PF00675 0.550
CLV_PCSK_FUR_1 423 427 PF00082 0.354
CLV_PCSK_KEX2_1 161 163 PF00082 0.306
CLV_PCSK_KEX2_1 307 309 PF00082 0.511
CLV_PCSK_KEX2_1 358 360 PF00082 0.421
CLV_PCSK_KEX2_1 394 396 PF00082 0.593
CLV_PCSK_KEX2_1 425 427 PF00082 0.516
CLV_PCSK_KEX2_1 496 498 PF00082 0.511
CLV_PCSK_KEX2_1 504 506 PF00082 0.377
CLV_PCSK_KEX2_1 71 73 PF00082 0.409
CLV_PCSK_PC1ET2_1 161 163 PF00082 0.350
CLV_PCSK_PC1ET2_1 425 427 PF00082 0.483
CLV_PCSK_PC1ET2_1 496 498 PF00082 0.494
CLV_PCSK_PC1ET2_1 71 73 PF00082 0.423
CLV_PCSK_PC7_1 303 309 PF00082 0.504
CLV_PCSK_SKI1_1 162 166 PF00082 0.306
CLV_PCSK_SKI1_1 2 6 PF00082 0.369
CLV_PCSK_SKI1_1 308 312 PF00082 0.529
CLV_PCSK_SKI1_1 369 373 PF00082 0.401
CLV_PCSK_SKI1_1 379 383 PF00082 0.365
CLV_PCSK_SKI1_1 516 520 PF00082 0.509
DEG_Nend_UBRbox_1 1 4 PF02207 0.464
DEG_SPOP_SBC_1 213 217 PF00917 0.388
DOC_CYCLIN_RxL_1 159 167 PF00134 0.430
DOC_CYCLIN_RxL_1 376 385 PF00134 0.498
DOC_CYCLIN_yCln2_LP_2 22 28 PF00134 0.374
DOC_MAPK_gen_1 338 346 PF00069 0.432
DOC_MAPK_gen_1 394 401 PF00069 0.530
DOC_MAPK_gen_1 435 444 PF00069 0.560
DOC_MAPK_gen_1 514 522 PF00069 0.481
DOC_MAPK_MEF2A_6 339 348 PF00069 0.414
DOC_MAPK_MEF2A_6 514 522 PF00069 0.481
DOC_MAPK_RevD_3 147 162 PF00069 0.306
DOC_USP7_MATH_1 134 138 PF00917 0.313
DOC_USP7_MATH_1 213 217 PF00917 0.430
DOC_USP7_MATH_1 268 272 PF00917 0.428
DOC_USP7_MATH_1 293 297 PF00917 0.633
DOC_USP7_MATH_1 351 355 PF00917 0.347
DOC_USP7_MATH_1 58 62 PF00917 0.307
DOC_WW_Pin1_4 148 153 PF00397 0.325
DOC_WW_Pin1_4 181 186 PF00397 0.369
DOC_WW_Pin1_4 315 320 PF00397 0.530
DOC_WW_Pin1_4 491 496 PF00397 0.465
DOC_WW_Pin1_4 81 86 PF00397 0.388
LIG_14-3-3_CanoR_1 303 307 PF00244 0.525
LIG_14-3-3_CanoR_1 497 503 PF00244 0.459
LIG_14-3-3_CanoR_1 504 509 PF00244 0.398
LIG_14-3-3_CanoR_1 72 80 PF00244 0.376
LIG_Actin_WH2_2 105 121 PF00022 0.249
LIG_Actin_WH2_2 343 360 PF00022 0.418
LIG_BRCT_BRCA1_1 499 503 PF00533 0.505
LIG_BRCT_BRCA1_1 60 64 PF00533 0.399
LIG_FHA_1 316 322 PF00498 0.541
LIG_FHA_1 403 409 PF00498 0.491
LIG_FHA_1 439 445 PF00498 0.454
LIG_FHA_1 73 79 PF00498 0.423
LIG_FHA_1 85 91 PF00498 0.423
LIG_FHA_2 152 158 PF00498 0.368
LIG_FHA_2 194 200 PF00498 0.384
LIG_FHA_2 326 332 PF00498 0.561
LIG_FHA_2 474 480 PF00498 0.446
LIG_FHA_2 89 95 PF00498 0.423
LIG_LIR_Apic_2 341 345 PF02991 0.403
LIG_LIR_Gen_1 140 149 PF02991 0.306
LIG_LIR_Gen_1 199 209 PF02991 0.279
LIG_LIR_Gen_1 215 226 PF02991 0.356
LIG_LIR_LC3C_4 439 444 PF02991 0.464
LIG_LIR_Nem_3 140 144 PF02991 0.306
LIG_LIR_Nem_3 198 204 PF02991 0.327
LIG_LIR_Nem_3 215 221 PF02991 0.222
LIG_LIR_Nem_3 304 309 PF02991 0.528
LIG_LIR_Nem_3 341 346 PF02991 0.400
LIG_LIR_Nem_3 362 367 PF02991 0.359
LIG_LRP6_Inhibitor_1 221 227 PF00058 0.366
LIG_PALB2_WD40_1 338 346 PF16756 0.476
LIG_PCNA_TLS_4 358 365 PF02747 0.405
LIG_SH2_STAT3 101 104 PF00017 0.405
LIG_SH2_STAT3 126 129 PF00017 0.366
LIG_SH2_STAT5 101 104 PF00017 0.375
LIG_SH2_STAT5 231 234 PF00017 0.306
LIG_SH3_3 146 152 PF00018 0.325
LIG_SUMO_SIM_anti_2 215 223 PF11976 0.336
LIG_SUMO_SIM_par_1 439 446 PF11976 0.526
LIG_TRAF2_1 320 323 PF00917 0.584
LIG_TRAF2_1 328 331 PF00917 0.618
LIG_TRAF2_1 477 480 PF00917 0.477
LIG_TYR_ITIM 113 118 PF00017 0.436
LIG_UBA3_1 381 386 PF00899 0.491
LIG_WRC_WIRS_1 444 449 PF05994 0.509
MOD_CDC14_SPxK_1 184 187 PF00782 0.433
MOD_CDC14_SPxK_1 494 497 PF00782 0.493
MOD_CDK_SPK_2 491 496 PF00069 0.447
MOD_CDK_SPxK_1 181 187 PF00069 0.385
MOD_CDK_SPxK_1 491 497 PF00069 0.473
MOD_CK1_1 151 157 PF00069 0.403
MOD_CK1_1 191 197 PF00069 0.366
MOD_CK1_1 263 269 PF00069 0.544
MOD_CK1_1 302 308 PF00069 0.607
MOD_CK1_1 524 530 PF00069 0.511
MOD_CK2_1 134 140 PF00069 0.306
MOD_CK2_1 193 199 PF00069 0.380
MOD_CK2_1 214 220 PF00069 0.303
MOD_CK2_1 317 323 PF00069 0.565
MOD_CK2_1 325 331 PF00069 0.576
MOD_CK2_1 416 422 PF00069 0.512
MOD_CK2_1 473 479 PF00069 0.475
MOD_GlcNHglycan 256 259 PF01048 0.628
MOD_GlcNHglycan 295 298 PF01048 0.599
MOD_GlcNHglycan 334 337 PF01048 0.548
MOD_GlcNHglycan 418 421 PF01048 0.525
MOD_GlcNHglycan 448 451 PF01048 0.467
MOD_GlcNHglycan 7 10 PF01048 0.305
MOD_GSK3_1 208 215 PF00069 0.355
MOD_GSK3_1 263 270 PF00069 0.448
MOD_GSK3_1 520 527 PF00069 0.510
MOD_GSK3_1 80 87 PF00069 0.361
MOD_N-GLC_1 188 193 PF02516 0.407
MOD_N-GLC_1 402 407 PF02516 0.345
MOD_N-GLC_1 497 502 PF02516 0.501
MOD_NEK2_1 156 161 PF00069 0.363
MOD_NEK2_1 17 22 PF00069 0.150
MOD_NEK2_1 212 217 PF00069 0.311
MOD_NEK2_1 292 297 PF00069 0.503
MOD_NEK2_1 352 357 PF00069 0.356
MOD_NEK2_1 399 404 PF00069 0.390
MOD_NEK2_1 416 421 PF00069 0.323
MOD_NEK2_1 438 443 PF00069 0.529
MOD_NEK2_1 5 10 PF00069 0.311
MOD_NEK2_1 520 525 PF00069 0.446
MOD_NEK2_1 80 85 PF00069 0.382
MOD_NEK2_1 97 102 PF00069 0.251
MOD_NEK2_2 268 273 PF00069 0.516
MOD_PIKK_1 100 106 PF00454 0.348
MOD_PKA_1 338 344 PF00069 0.439
MOD_PKA_1 496 502 PF00069 0.460
MOD_PKA_1 504 510 PF00069 0.348
MOD_PKA_2 302 308 PF00069 0.524
MOD_PKA_2 485 491 PF00069 0.526
MOD_PKA_2 496 502 PF00069 0.462
MOD_PKA_2 504 510 PF00069 0.421
MOD_Plk_1 139 145 PF00069 0.306
MOD_Plk_1 156 162 PF00069 0.306
MOD_Plk_1 322 328 PF00069 0.577
MOD_Plk_1 438 444 PF00069 0.528
MOD_Plk_4 17 23 PF00069 0.403
MOD_Plk_4 214 220 PF00069 0.307
MOD_Plk_4 260 266 PF00069 0.499
MOD_Plk_4 338 344 PF00069 0.439
MOD_Plk_4 438 444 PF00069 0.531
MOD_Plk_4 504 510 PF00069 0.556
MOD_Plk_4 97 103 PF00069 0.362
MOD_ProDKin_1 148 154 PF00069 0.325
MOD_ProDKin_1 181 187 PF00069 0.369
MOD_ProDKin_1 315 321 PF00069 0.533
MOD_ProDKin_1 491 497 PF00069 0.473
MOD_ProDKin_1 81 87 PF00069 0.388
TRG_DiLeu_BaEn_4 322 328 PF01217 0.564
TRG_DiLeu_BaLyEn_6 342 347 PF01217 0.524
TRG_ENDOCYTIC_2 115 118 PF00928 0.433
TRG_ER_diArg_1 306 308 PF00400 0.509
TRG_ER_diArg_1 357 359 PF00400 0.400
TRG_ER_diArg_1 503 505 PF00400 0.547
TRG_Pf-PMV_PEXEL_1 162 167 PF00026 0.430

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1IJM7 Leptomonas seymouri 67% 94%
A0A0S4IR28 Bodo saltans 38% 99%
A0A1X0P5F7 Trypanosomatidae 52% 97%
A0A3Q8IGH2 Leishmania donovani 94% 100%
A0A422NRA5 Trypanosoma rangeli 51% 99%
A4HN14 Leishmania braziliensis 81% 100%
A4IBN7 Leishmania infantum 95% 100%
C9ZYZ4 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 51% 97%
E9B6M6 Leishmania mexicana (strain MHOM/GT/2001/U1103) 92% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS